Adeeb Sheet Dereen, Bibani Rashid Hamid, Kheder Azad Hasan
Master Degree in Pharmacology, Department of Medical Education, College of Medicine, Hawler Medical University, Erbil, Kurdistan Region-Iraq.
PhD Clinical Neurology, Department of Medicine, College of Medicine, Hawler Medical University, Erbil, Kurdistan Region-Iraq.
Cell Mol Biol (Noisy-le-grand). 2022 Nov 30;68(11):37-42. doi: 10.14715/cmb/2022.68.11.7.
Acute migraine attacks disrupt performance and reduce the quality of life. Therefore, efforts to prevent these attacks continue using different medications. This study aimed to compare the effect of cinnarizine combination with propranolol and propranolol with placebo in preventing acute migraine attacks. This study was a semi-experimental study performed on 120 adult patients with migraine referred to Department of Neurology in Rezgary Teaching Hospital in Erbil.. Participants were randomly allocated to two groups control (propranolol) and intervention (propranolol with cinnarizine). The frequency, duration and severity of headache attacks were recorded and followed within two months. Data were analyzed with SPSS ver23 software and T-paired, independent T-tests and ANOVA. The average age of the participants was 34.54 years. 60% were female and 55% had a family history of migraine. The average frequency of headache attacks in the intervention group decreased by 75 % (from 15 times to 3 times) and a 50 % decrease in the control group (from 12 times to 6 times). The duration and severity of headaches in both intervention and control groups decreased (p <0.001), respectively. The average frequency, duration and severity of headache attacks in the first- and second months during treatment in the intervention group and control group were statistically different (p <0.001). The drug combination of propranolol with cinnarizine has an additional effect on reducing acute migraine attacks compared to propranolol alone.
急性偏头痛发作会干扰日常活动并降低生活质量。因此,人们一直在努力使用不同药物来预防这些发作。本研究旨在比较桂利嗪联合普萘洛尔与普萘洛尔联合安慰剂预防急性偏头痛发作的效果。本研究是一项半实验性研究,对120名转诊至埃尔比勒雷扎加里教学医院神经科的成年偏头痛患者进行。参与者被随机分为两组,对照组(普萘洛尔)和干预组(普萘洛尔联合桂利嗪)。记录头痛发作的频率、持续时间和严重程度,并在两个月内进行跟踪。数据使用SPSS 23软件进行分析,并采用配对t检验、独立t检验和方差分析。参与者的平均年龄为34.54岁。60%为女性,55%有偏头痛家族史。干预组头痛发作的平均频率下降了75%(从15次降至3次),对照组下降了50%(从12次降至6次)。干预组和对照组头痛的持续时间和严重程度均有所下降(p<0.001)。干预组和对照组治疗期间第一个月和第二个月头痛发作的平均频率、持续时间和严重程度在统计学上存在差异(p<0.001)。与单独使用普萘洛尔相比,普萘洛尔与桂利嗪的药物组合在减少急性偏头痛发作方面具有额外的效果。